Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient

Abstract Background Pandoraea species are multidrug-resistant glucose-nonfermenting gram-negative bacilli that are usually isolated from patients with cystic fibrosis (CF) and from water and soil. Reports of diseases, including bloodstream infections, caused by Pandoraea spp. in non-CF patients are...

Full description

Bibliographic Details
Main Authors: Naoya Itoh, Nana Akazawa, Yuichi Ishibana, Toshiki Masuishi, Akinobu Nakata, Hiromi Murakami
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-022-07514-z
_version_ 1818212046589657088
author Naoya Itoh
Nana Akazawa
Yuichi Ishibana
Toshiki Masuishi
Akinobu Nakata
Hiromi Murakami
author_facet Naoya Itoh
Nana Akazawa
Yuichi Ishibana
Toshiki Masuishi
Akinobu Nakata
Hiromi Murakami
author_sort Naoya Itoh
collection DOAJ
description Abstract Background Pandoraea species are multidrug-resistant glucose-nonfermenting gram-negative bacilli that are usually isolated from patients with cystic fibrosis (CF) and from water and soil. Reports of diseases, including bloodstream infections, caused by Pandoraea spp. in non-CF patients are rare, and the clinical and microbiological characteristics are unclear. The identification of Pandorea spp. is limited by conventional microbiological methods and may be misidentified as other species owing to overlapping biochemical profiles. Here, we report the first case of obstructive cholangitis with bacteremia caused by Pandoraea apista in a patient with advanced colorectal cancer. A 61-year-old man with advanced colorectal cancer who underwent right nephrectomy for renal cell carcinoma 4 years earlier with well-controlled diabetes mellitus was admitted to our hospital with fever for 2 days. The last chemotherapy (regorafenib) was administered approximately 3 weeks ago, and an endoscopic ultrasound-guided hepaticogastrostomy was performed 2 weeks ago under hospitalization for obstructive jaundice. Two days prior, he presented with fever with chills. He was treated with piperacillin-tazobactam for obstructive cholangitis and showed improvement but subsequently presented with exacerbation. Bacterial isolates from the blood and bile samples were identified as P. apista using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 16S ribosomal RNA sequencing. Based on the susceptibility results of the isolates, he was successfully treated with oral trimethoprim-sulfamethoxazole 160 mg/800 mg/day for 14 days for P. apista infection. Conclusions Pandoraea species are often misidentified. Therefore, multiple approaches should be used to identify them, and decisions regarding antimicrobial treatment should be based on actual in vitro susceptibility. Only seven cases of Pandoraea spp. bloodstream infections have been reported, and we report the first case of cholangitis with bacteremia.
first_indexed 2024-12-12T05:42:10Z
format Article
id doaj.art-1d7b1a5fce794f90a5cddcdd26859e76
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-12T05:42:10Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-1d7b1a5fce794f90a5cddcdd26859e762022-12-22T00:35:52ZengBMCBMC Infectious Diseases1471-23342022-06-012211710.1186/s12879-022-07514-zClinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patientNaoya Itoh0Nana Akazawa1Yuichi Ishibana2Toshiki Masuishi3Akinobu Nakata4Hiromi Murakami5Division of Infectious Diseases, Aichi Cancer Center HospitalDivision of Infectious Diseases, Aichi Cancer Center HospitalDivision of Infectious Diseases, Aichi Cancer Center HospitalDepartment of Clinical Oncology, Aichi Cancer Center HospitalDepartment of Clinical Oncology, Aichi Cancer Center HospitalDivision of Infectious Diseases, Aichi Cancer Center HospitalAbstract Background Pandoraea species are multidrug-resistant glucose-nonfermenting gram-negative bacilli that are usually isolated from patients with cystic fibrosis (CF) and from water and soil. Reports of diseases, including bloodstream infections, caused by Pandoraea spp. in non-CF patients are rare, and the clinical and microbiological characteristics are unclear. The identification of Pandorea spp. is limited by conventional microbiological methods and may be misidentified as other species owing to overlapping biochemical profiles. Here, we report the first case of obstructive cholangitis with bacteremia caused by Pandoraea apista in a patient with advanced colorectal cancer. A 61-year-old man with advanced colorectal cancer who underwent right nephrectomy for renal cell carcinoma 4 years earlier with well-controlled diabetes mellitus was admitted to our hospital with fever for 2 days. The last chemotherapy (regorafenib) was administered approximately 3 weeks ago, and an endoscopic ultrasound-guided hepaticogastrostomy was performed 2 weeks ago under hospitalization for obstructive jaundice. Two days prior, he presented with fever with chills. He was treated with piperacillin-tazobactam for obstructive cholangitis and showed improvement but subsequently presented with exacerbation. Bacterial isolates from the blood and bile samples were identified as P. apista using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 16S ribosomal RNA sequencing. Based on the susceptibility results of the isolates, he was successfully treated with oral trimethoprim-sulfamethoxazole 160 mg/800 mg/day for 14 days for P. apista infection. Conclusions Pandoraea species are often misidentified. Therefore, multiple approaches should be used to identify them, and decisions regarding antimicrobial treatment should be based on actual in vitro susceptibility. Only seven cases of Pandoraea spp. bloodstream infections have been reported, and we report the first case of cholangitis with bacteremia.https://doi.org/10.1186/s12879-022-07514-zPandoraea apistaMatrix-assisted laser desorption/ionization time-of-flight mass spectrometryRibosomal RNA sequencingCholangitisBloodstream infectionBacteremia
spellingShingle Naoya Itoh
Nana Akazawa
Yuichi Ishibana
Toshiki Masuishi
Akinobu Nakata
Hiromi Murakami
Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
BMC Infectious Diseases
Pandoraea apista
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Ribosomal RNA sequencing
Cholangitis
Bloodstream infection
Bacteremia
title Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
title_full Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
title_fullStr Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
title_full_unstemmed Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
title_short Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient
title_sort clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by pandoraea apista identified by maldi tof mass spectrometry and ribosomal rna sequencing in a cancer patient
topic Pandoraea apista
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Ribosomal RNA sequencing
Cholangitis
Bloodstream infection
Bacteremia
url https://doi.org/10.1186/s12879-022-07514-z
work_keys_str_mv AT naoyaitoh clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient
AT nanaakazawa clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient
AT yuichiishibana clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient
AT toshikimasuishi clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient
AT akinobunakata clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient
AT hiromimurakami clinicalandmicrobiologicalfeaturesofobstructivecholangitiswithbloodstreaminfectioncausedbypandoraeaapistaidentifiedbymalditofmassspectrometryandribosomalrnasequencinginacancerpatient